Skip to main content
AVTX filings

Corporate insider profile

Mittie Doyle Filing Activity

Latest reported as Chief Medical Officer of Avalo Therapeutics, Inc. (AVTX).

Purchase filings
0
Reported companies
1
Net open-market value
-$2,323,611.21
Latest transaction
Jun 23, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 23, 2026Avalo Therapeutics, Inc. (AVTX)Chief Medical OfficerSale1,450$18.00$26,100
May 28, 2026Avalo Therapeutics, Inc. (AVTX)Chief Medical OfficerSale679$16.00$10,864
May 15, 2026Avalo Therapeutics, Inc. (AVTX)Chief Medical OfficerSale3,000$18.76$56,280